Clinical Trials Logo

Filter by:
  • Completed  
  • « Prev · Page [39]
NCT ID: NCT00041275 Completed - Liver Cancer Clinical Trials

Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Start date: May 2002
Phase: Phase 3
Study type: Interventional

RATIONALE: Estrogen can stimulate the growth of cancer cells. Hormone therapy using megestrol may fight liver cancer by blocking the uptake of estrogen. It is not yet known if megestrol is an effective treatment for liver cancer. PURPOSE: Randomized phase III trial to determine the effectiveness of megestrol in treating patients who have liver cancer that cannot be removed by surgery.